3rd Circ. Declines To Hear Mylan, Celgene Antitrust Fight
The Third Circuit on Thursday rejected Celgene Corp.'s bid for an immediate review of a New Jersey federal judge's decision not to toss Mylan Pharmaceuticals Inc.'s antitrust suit accusing Celgene of...To view the full article, register now.
Already a subscriber? Click here to view full article